335 related articles for article (PubMed ID: 27923369)
21. Long-term treatment reduction and steroids withdrawal in children with autoimmune hepatitis: a single centre experience on 55 children.
Dumortier J; Arita CT; Rivet C; LeGall C; Bouvier R; Fabien N; Guillaud O; Collardeau-Frachon S; Scoazec JY; Lachaux A
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1413-8. PubMed ID: 19907227
[TBL] [Abstract][Full Text] [Related]
22. Gutuo Jiejiu decoction improves survival of patients with severe alcoholic hepatitis: A retrospective cohort study.
Mou HY; Nie HM; Hu XY
World J Gastroenterol; 2017 Apr; 23(16):2957-2963. PubMed ID: 28522913
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune hepatitis in patients with human immunodeficiency virus (HIV): Case reports of a rare, but important diagnosis with therapeutic implications.
Kia L; Beattie A; Green RM
Medicine (Baltimore); 2017 Feb; 96(7):e6011. PubMed ID: 28207511
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of Shu-gan-qing-re formula for generalized anxiety disorder: study protocol for a multi-center, prospective, double-blind, double-dummy, randomized controlled trial.
Chen P; Zhu H; Ning Y; Yin D; Jia H
Trials; 2020 Mar; 21(1):266. PubMed ID: 32171323
[TBL] [Abstract][Full Text] [Related]
25. Therapy of autoimmune hepatitis.
Strassburg CP; Manns MP
Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):673-87. PubMed ID: 22117634
[TBL] [Abstract][Full Text] [Related]
26. [Autoimmune hepatitis in pediatric patients].
García Romero R; Martín de Carpi J; Bernal Cuartas C; Pinillos Pisón S; Varea Calderón V
Rev Esp Enferm Dig; 2007 May; 99(5):255-8. PubMed ID: 17650933
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
[TBL] [Abstract][Full Text] [Related]
28. The use of budesonide in the treatment of autoimmune hepatitis in Canada.
Zandieh I; Krygier D; Wong V; Howard J; Worobetz L; Minuk G; Witt-Sullivan H; Yoshida EM
Can J Gastroenterol; 2008 Apr; 22(4):388-92. PubMed ID: 18414714
[TBL] [Abstract][Full Text] [Related]
29. Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Banerjee S; Rahhal R; Bishop WP
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):353-6. PubMed ID: 16954959
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune hepatitis: Current and future therapeutic options.
Doycheva I; Watt KD; Gulamhusein AF
Liver Int; 2019 Jun; 39(6):1002-1013. PubMed ID: 30716203
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis.
O'Brien C; Joshi S; Feld JJ; Guindi M; Dienes HP; Heathcote EJ
Hepatology; 2008 Aug; 48(2):550-6. PubMed ID: 18666262
[TBL] [Abstract][Full Text] [Related]
33. The use of immunosuppression in autoimmune hepatitis: A current literature review.
Cropley A; Weltman M
Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
Chua KK; Wong A; Kwan PW; Song JX; Chen LL; Chan AL; Lu JH; Mok V; Li M
Trials; 2015 Apr; 16():199. PubMed ID: 25925312
[TBL] [Abstract][Full Text] [Related]
35. Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.
Llovet LP; Horta D; Eliz MG; Berenguer M; Fábrega E; Sáez-Royuela F; García-Retortillo M; Torrijos YS; Romero-Gómez M; Fernández C; Domínguez EG; Parés A; Londoño MC
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2819-2821. PubMed ID: 30616023
[TBL] [Abstract][Full Text] [Related]
36. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
[TBL] [Abstract][Full Text] [Related]
37. Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
Purnak T; Efe C; Kav T; Wahlin S; Ozaslan E
Dig Dis Sci; 2017 Oct; 62(10):2900-2907. PubMed ID: 28871464
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy.
Seela S; Sheela H; Boyer JL
Liver Int; 2005 Aug; 25(4):734-9. PubMed ID: 15998423
[TBL] [Abstract][Full Text] [Related]
39. Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.
van den Brand FF; van Nieuwkerk CMJ; Verwer BJ; de Boer YS; de Boer NKH; Mulder CJJ; Bloemena E; Bakker CM; Vrolijk JM; Drenth JPH; Tan ACITL; Ter Borg F; Ter Borg MJ; van den Hazel SJ; Inderson A; Tushuizen ME; Bouma G
Aliment Pharmacol Ther; 2018 Oct; 48(7):761-767. PubMed ID: 30109891
[TBL] [Abstract][Full Text] [Related]
40. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.
Burak KW; Swain MG; Santodomingo-Garzon T; Lee SS; Urbanski SJ; Aspinall AI; Coffin CS; Myers RP
Can J Gastroenterol; 2013; 27(5):273-80. PubMed ID: 23712302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
